February 8, 2024
How One Type of Lung Cancer Can Transform into Another
Weill Cornell Medicine scientists create a mouse model to study lung cancer’s transformation into deadly SCLC.
Weill Cornell Medicine
Research News
Explore our curated selection of the latest breakthroughs in lung cancer research.
February 8, 2024
Weill Cornell Medicine scientists create a mouse model to study lung cancer’s transformation into deadly SCLC.
Weill Cornell Medicine
January 31, 2024
Researchers who conducted a large study published in the journal Chest report that reproductive factors, such as early age at menopause and first childbirth, are associated with an increased risk of lung cancer.
Medical News Today
January 27, 2024
Actress and comedian Kate Micucci, revealed last month that she had been diagnosed and treated for lung cancer despite having “never” smoked cigarettes. Micucci’s diagnosis came as a surprise to her followers, especially considering she is a non-smoker. However, lung cancer among non-smokers happens more often than most people realize.
WesternSlopeNow.com
January 23, 2024
Study finds lung cancer patients show distinct lung microbiome profiles versus benign diseases. Analyzing microbial features in bronchoalveolar lavage fluid could serve as minimally invasive biomarker for lung cancer detection, reducing need for biopsies.
News-Medical.Net
January 18, 2024
Ohio State launched a mobile lung cancer screening unit to increase early detection statewide by bringing expert staff & the latest diagnostic tech to underserved areas. The goal is to boost screening rates.
OSUCCC
January 16, 2024
Study finds NSCLC patients treated with low-dose radiation & immunotherapy had higher progression-free survival than with immunotherapy alone – combo extended PFS and bolstered immune response.
Cornell Chronicle
January 1, 2024
David P. Carbone, MD, PhD, sought to transform lung cancer care and did it—but didn’t anticipate the personal journey it would put him on.
OncLive
December 6, 2023
Changing the current lung cancer guidelines to a 2-year smoking duration cutoff vs a 20 pack-year cutoff would significantly improve the rate of cancer detection and reduce racial disparities with screenings.
Oncology Nursing News
November 29, 2023
LUMINOSITY trial demonstrated compelling clinical benefits across key endpoints. Teliso-V is an investigational first-in-class, c-Met protein directed antibody-drug conjugate (ADC) being studied in patients with previously treated non-small cell lung cancer (NSCLC) with c-Met overexpression.
AbbVie
November 22, 2023
Artificial intelligence (AI) assessments of chest X-rays identified 28% of never-smokers as being at high-risk for lung cancer, according to research to be presented at the annual Radiological Society of North America (RSNA) conference next week.
Diagnostic Imaging
November 15, 2023
The FDA has approved repotrectinib (Augtyro) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non–small cell lung cancer.
OncLive
October 19, 2023
Recent studies confirm genomic testing for NSCLC enhances treatment choices and survival, advocating for its standardization in clinical practice.
OncLive
Learn more about:
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers.